Scintigraphic evaluation of cardiac metabolism in multicentric Castleman's disease

Intern Med. 2004 Jun;43(6):490-2. doi: 10.2169/internalmedicine.43.490.

Abstract

A 72-year-old woman had insidious onset of heart failure, and was diagnosed as multicentric Castleman's disease. She underwent myocardial imaging with technetium-99m tetrofosmin, 1-123 beta-methyl-iodophenyl pentadecanoic acid (BMIPP). Technetium-99m tetrofosmin studies showed almost normal uptake of the left ventricular myocardium indicating normal myocardial perfusion. 1-123 BMIPP showed reduced uptake in the apical segment of the myocardium, indicating regional fatty acid metabolic abnormalities.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Castleman Disease / complications
  • Castleman Disease / diagnostic imaging*
  • Fatty Acids / metabolism
  • Female
  • Heart Failure / diagnostic imaging*
  • Heart Failure / etiology
  • Humans
  • Iodobenzenes
  • Metabolic Diseases / complications
  • Metabolic Diseases / diagnostic imaging*
  • Metabolic Diseases / metabolism
  • Myocardium / metabolism
  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Technetium
  • Tomography, Emission-Computed, Single-Photon / methods*

Substances

  • Fatty Acids
  • Iodobenzenes
  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • iodofiltic acid
  • technetium tc-99m tetrofosmin
  • Technetium